Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up - Test2 - elhamkhani - TriplyDB

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

http://www.wikidata.org/entity/Q28182929

about

Review of evidence for use of antidepressants in bipolar depression An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders The psychopathology and treatment of bipolar disorder.Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany.Burden of illness in bipolar depression.Antidepressant chronotherapeutics for bipolar depression.Managing bipolar depression Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Bipolar depression: trial-based insights to guide patient care.Treatment strategies for bipolar disorder: CALM SEA Management of Bipolar II Disorder Recent developments in the treatment of bipolar disorders.Impact of bipolar disorder: results from a screening study.Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial Bipolar II disorder: a review.Treatment of bipolar depression: focus on pharmacologic therapies.Maintenance therapies in bipolar disorder: focus on randomized controlled trials.Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression.Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review.Antidepressants and suicidal behavior in bipolar disorder.Bipolar depression: diagnostic and treatment considerations.Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder.Clinical challenges of bipolar depression.Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states?Overview of antidepressant treatment of bipolar depression.Treatment response and duration of maintenance treatment with adjunctive antidepressants in bipolar depression: A retrospective chart review.Treating bipolar depression - antidepressants and alternatives: a critical review of the literature.Lithium: A classic drug-Frequently discussed, but, sadly, seldom prescribed!

P2860

Q26824365-C54E9F25-2F61-489E-B6FF-C4A6792C69FF Q30482552-6904DEE3-EDB2-4D3E-A500-69C55FDA4735 Q30534769-F05ACA38-BABF-4C4E-98EA-53E82752A9B7 Q30569917-E13D1B57-95F4-4AE7-BD5F-935F0145C66F Q30583384-57B37060-593F-49C8-8F58-285127049C48 Q33619910-9464BDAD-8AB0-4FD0-A770-5113A5A01CDF Q34165024-FD77F007-F820-4838-A69E-3B51F475F973 Q34248110-E8244F95-1DB5-43F4-89E4-51D1474E98D6 Q34326871-921C85AB-89D1-4038-B5D3-907474922744 Q34343896-DD9BABCA-87A1-4DE0-954B-828A2E16B7A7 Q34433880-B31C5B88-D70F-447E-9612-9118E308D076 Q34550618-973EF91F-13D1-4B08-82CF-8BC94BD1FD51 Q34616633-4DA5B5E5-4CCC-434D-8652-236D3E05D172 Q34649187-3E84D998-39E5-4687-8502-C4A42E37A7E0 Q34676317-F8D6C87D-3D95-432A-89B8-14EF811CEE66 Q34823805-7C8457B8-527F-4609-B9A3-1B455FBF186B Q35236988-79237328-4C8E-4420-9FDF-1B822C02AE0E Q35251929-BDC8786F-CA68-4B0B-B49D-E3362C6765A7 Q35365581-B727DCA6-B443-4C3A-AF7C-5E5E7B740554 Q35547289-E7F2328B-E36D-4133-AA0C-8096D5814D34 Q35847010-1370F9DD-CA5E-4B64-82A2-B0BA6B031715 Q35967580-F64C8D7C-7827-4DE8-A6B2-C7E768B1C51C Q36005762-CFD833F3-6E37-42C0-9576-91372CC79630 Q36011833-F7F5D14F-B84E-4A27-9871-31B6F3551384 Q36106769-E26414B4-0F68-4A15-AC48-76E602776740 Q36210974-6CF5BB7F-0A85-4EF6-96B7-9EE6B6FD6208 Q36286401-56366B79-2B6D-4D18-A469-1F03EBFE2B7E Q36307086-C71252B8-B95A-4BC8-AD82-58F7FBFC5C90 Q36624146-277B58FA-2D5F-45E5-80EA-8B107976A95D Q36634433-472F2337-40D4-412B-871F-4921651B29DE Q36807661-D3BA7DF1-399F-4717-AA5A-0A26588F5F3E Q36987370-8AC1BD8E-4FE4-487D-BC4B-FAB53A7A6D58 Q37115466-1109F574-3AE1-46F7-8412-5777E7E78BED Q37219396-D5CB4157-7EB6-4A31-92B7-16344D6105D6 Q37347736-2578E250-7403-4931-8079-A27980846735 Q38040453-37393E87-CEC3-4E20-A3C4-4273BC2C86E4 Q38083305-2F62AE20-D74D-4549-AF8F-FC666AD821AE Q38219318-4BF74A58-C852-42F7-8A0E-874B02AAFCEC Q38764892-9A412BF9-8E82-4AD3-9762-4AFA746B080D Q39238241-F6FF6BBB-EB9A-4355-A9CB-59561017EE27

P2860

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

http://www.wikidata.org/entity/Q28182929

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@ast

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@en

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@nl

type

label

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@ast

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@en

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@nl

prefLabel

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@ast

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@en

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@nl

P1433

Q28182929-1DCD3CA7-1D3B-4AFE-BEF7-6248F9B987F3

P1476

Q28182929-F0B064A0-A0C1-4F80-931A-83131E418B59

P2093

Q28182929-1243827A-E357-46CD-A0D4-0C34AC278BE6

Q28182929-1AE7E426-1C36-4FAE-BA7D-A38913D2DF3D

Q28182929-3B22B2F9-4994-4F1A-9BEB-4361D6557862

Q28182929-3EF096A5-36C2-4CC5-AD45-04CFEB62A79D

Q28182929-49C897F2-69B8-4471-B3E6-6B3CB36B2DE1

Q28182929-5E450A75-99AC-44BF-9039-CBC71E963495

Q28182929-5F0E4B0A-68FF-411E-B4E8-85DDBD221D84

Q28182929-6729A177-1B26-40E4-85AA-F3833AE499BA

Q28182929-6F61003F-EC59-445C-93AE-A01B8689A7D1

Q28182929-7BAA388F-7FD2-43E0-9D4B-F75A39D2D150

P304

Q28182929-0E71CD07-228B-4060-BD2E-771F65652BAC

P31

Q28182929-20CCD743-27D7-450C-965B-3D0DD32434A3

P356

Q28182929-4EA98AC0-0674-4DF4-A154-E74291730AFF

P407

Q28182929-61CA5596-D31A-430F-A09E-5BE8FF5437BB

P433

Q28182929-3E4CE817-D73C-4C2F-B18B-5F4D93963D01

P478

Q28182929-3280F8FF-4DFF-4EB9-A5CA-8394C1C08434

P50

Q28182929-10D5995C-BAC9-4798-A788-95AAE64DB5C7

P577

Q28182929-99401D7E-1E32-469B-ADE5-8A1BC67F2578

P5875

Q28182929-DF4EC50A-C0E2-4572-8BD1-A924279E364F

P698

Q28182929-6E7956D5-6FBF-47F9-8DCD-EB5D38BA3A2D

P356

APPI.AJP.160.7.1252

P1433

American Journal of Psychiatry

P1476

Impact of antidepressant disco ...... ve relapse at 1-year follow-up

@en

P2093

David Black

http://www.w3.org/2001/XMLSchema#string

David Luckenbaugh

http://www.w3.org/2001/XMLSchema#string

Gabrielle Leverich

http://www.w3.org/2001/XMLSchema#string

Jörg Walden

http://www.w3.org/2001/XMLSchema#string

Kirk Denicoff

http://www.w3.org/2001/XMLSchema#string

Lori Altshuler

http://www.w3.org/2001/XMLSchema#string

Mark A Frye

http://www.w3.org/2001/XMLSchema#string

Paul E Keck

http://www.w3.org/2001/XMLSchema#string

Ralph Kupka

http://www.w3.org/2001/XMLSchema#string

Robert Post

http://www.w3.org/2001/XMLSchema#string

P304

1252-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.160.7.1252

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10686317

http://www.w3.org/2001/XMLSchema#string

P698

12832239

http://www.w3.org/2001/XMLSchema#string